Biosimilars

Channel: Biosimilars

↧

Properties of TPI G-CSF in comparison to Neupogen®

:0

:0

November 2, 2015, 12:43 pm

Niazi SK

View Article

Adalimumab biosimilars

:0

:0

January 28, 2016, 12:40 pm

Gabbani T, Deiana S, Bagnoli S, Annese V

View Article

Biosimilar insulin devices

:0

:0

February 15, 2016, 2:16 pm

Fry AR, Krentz AJ, Hompesch M

View Article

Clinical efficacy and safety of Zarzio® (EP2006), a biosimilar...

:0

:0

March 11, 2014, 4:00 am

View Article

Production and analysis of a biosimilar erythropoietin in Egypt

:0

:0

May 9, 2014, 5:00 am

View Article

Multidisciplinary approach to evaluating immunogenicity of biosimilars:...

:0

:0

June 24, 2014, 5:00 am

View Article

Production and manufacturing of biosimilar insulins: implications for...

:0

:0

November 9, 2014, 3:15 pm

View Article

Physicochemical and functional characterization of a biosimilar adalimumab...

:0

:0

December 30, 2014, 3:04 pm

View Article

Global regulatory landscape of biosimilars: emerging and established market...

:0

:0

February 16, 2015, 1:08 pm

View Article

Challenging issues in assessing analytical similarity in biosimilar studies

:0

:0

May 21, 2015, 3:46 pm

View Article

Establishing a new marketplace for biologic therapy with biosimilar agents:...

:0

:0

May 31, 2015, 7:20 pm

View Article

Clinical trials in the development of biosimilars: future considerations

:0

:0

July 8, 2015, 10:31 pm

View Article

Clinical efficacy and safety of biosimilar epoetin: focus on epoetin zeta

:0

:0

September 8, 2015, 4:35 pm

View Article

Low immunogenicity but reduced bioavailability of an interferon beta-1a...

:0

:0

September 14, 2015, 4:40 pm

View Article

Label-free interaction analysis as a tool to demonstrate biosimilarity of...

:0

:0

September 15, 2015, 6:32 pm

View Article

Pharmacokinetic and pharmacodynamic properties of a new biosimilar filgrastim...

:0

:0

November 2, 2015, 4:56 pm

View Article

Development, safety, and efficacy of biosimilar adalimumab: the data so far

:0

:0

January 28, 2016, 4:56 pm

View Article

Considerations in biosimilar insulin device development

:0

:0

February 15, 2016, 5:49 pm

View Article

Tools for the analysis and characterization of therapeutic protein species

:0

:0

May 4, 2016, 8:02 pm

View Article

"Step" versus "phase" in the clinical development of...

:0

:0

June 21, 2016, 4:37 pm

View Article

© 2025 //www.rssing.com